Is it possible to distinguish between benign and malignant neutropenia in clozapine-treated patients by means of a hydrocortisone test?
Murry
P
P
Laurent
A
A
D000293:Adolescent; D000368:Aged; D000893:Anti-Inflammatory Agents / Q000494:pharmacology*; D014150:Antipsychotic Agents / Q000009:adverse effects*; D003024:Clozapine / Q000009:adverse effects*; D003937:Diagnosis, Differential; D005260:Female; D006801:Humans; D006854:Hydrocortisone / Q000008:administration & dosage; D007275:Injections, Intravenous; D007958:Leukocyte Count; D007962:Leukocytes / Q000187:drug effects / Q000378:metabolism; D008297:Male; D008875:Middle Aged; D009503:Neutropenia / Q000097:blood* / Q000139:chemically induced*; D009504:Neutrophils / Q000187:drug effects / Q000378:metabolism
D000893:Anti-Inflammatory Agents; D014150:Antipsychotic Agents; D003024:Clozapine; D006854:Hydrocortisone